Ontology highlight
ABSTRACT:
SUBMITTER: Sankar K
PROVIDER: S-EPMC6284603 | biostudies-literature | 2018 Nov-Dec
REPOSITORIES: biostudies-literature
Sankar Kannan K Hoi Kam Hon KH Yin Yizhou Y Ramachandran Prasanna P Andersen Nisana N Hilderbrand Amy A McDonald Paul P Spiess Christoph C Zhang Qing Q
mAbs 20180925 8
Monoclonal antibodies (mAbs) have become a major class of protein therapeutics that target a spectrum of diseases ranging from cancers to infectious diseases. Similar to any protein molecule, mAbs are susceptible to chemical modifications during the manufacturing process, long-term storage, and in vivo circulation that can impair their potency. One such modification is the oxidation of methionine residues. Chemical modifications that occur in the complementarity-determining regions (CDRs) of mAb ...[more]